KRAS and neoplasm: We employed a pair-wise association approach to assess the correlation between several mutations (KRAS Q61, KRAS G12 / G13, NRAS Q61, NRAS G12 / G13, BRAF, and EGFR) and also the associations between the mutations and histopathology features (tumor staging, inflammation, differentiation, and invasiveness).